News of Note—Abbott faces class-action suit over St. Jude defibrillators, and more

newspaper

Here is Wednesday's medtech news of note.

> St. Jude Medical investors are seeking class-action status in a lawsuit over allegations that the devicemaker—now part of Abbott—did not inform regulators about faulty batteries in its implantable defibrillators. MassDevice article

> Bayer has stopped sales of its Essure birth control implant outside the U.S. for commercial reasons and not safety issues, despite growing concern about the safety of the device. MarketWatch article | FierceMedTech article

Survey

Share your opinion. Take our five minute survey.

How do you select the most suitable advanced dosage forms for new molecules in your development pipelines? Share your insights in this 5-minute survey. The first 50 qualified respondents will receive a $5 Amazon gift card.

> Stryker’s Spine unit notched an FDA nod for its 3D-printed TritaniumC Anterior Cervical Cage. It will launch the device in the fourth quarter. Release

Suggested Articles

Boston Scientific’s deep brain stimulation implant for treating Parkinson’s disease has been approved by the FDA as safe to use within an MRI.

The FDA approved a new device for people suffering from advanced heart failure who are not able to receive treatment from other devices.

Alcon has announced plans to launch its daily disposable contact lens in the U.S. made from a new material.